NCT03146429已完成不适用
Prediction of Future Weight Change With Dopamine Transporter
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 200
- 主要终点
- Weight change
研究概览
简要总结
This is the re-analyzing study of observational study by Parkinson's Progression Markers Initiative
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 30 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •males or females with their age of 30 years or older at screening
排除标准
- •subjects with a neurological disorder, a first degree relative with idiopathic PD, Montreal Cognitive Assessment score of 26 or less, medications that might interfere with DAT SPECT scans, anticoagulants that might preclude safe completion of the lumbar puncture, or investigational drugs, and a condition that precludes the safe performance of routine lumbar puncture
结局指标
主要结局
Weight change
时间窗: 1, 2, 3, 4, 5 year after SPECT
weight change per year until 5 years after SPECT
次要结局
未报告次要终点
研究者
Kyoungjune Pak
Clinical Assistant Professor
Pusan National University Hospital
相似试验
已完成
2 期
Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease ProgressionParkinson DiseaseNCT00134784Institute for Neurodegenerative Disorders142
已完成
1 期
Measuring Parkinson's Disease ProgressionParkinson's DiseaseNCT03205956Kevin J. Black, MD31
招募中
不适用
Predictors of Parkinson's Disease ProgressionCognitive DysfunctionBiomarkersParkinson DiseaseNCT04062279Ain Shams University100
Unknown
不适用
Clinical Study on the Efficacy of Natural Stem Cell Mobilizers on Parkinson DiseaseParkinson DiseaseNCT05699694Sociedad Española de Medicina Regenerativa y Terapia Celular40
已完成
2 期
Assessing Imaging as a Tool in Monitoring and Predicting the Progression of Parkinson DiseaseParkinson DiseaseNCT00404170Institute for Neurodegenerative Disorders396